EMA publishes agenda for 26-29 January 2026 CHMP meeting

26 January 2026 - The EMA has published a draft agenda for this week's CHMP meeting. ...

Read more →

Minimal residual disease and complete response in multiple myeloma: use as outcomes to support accelerated approval

20 January 2026 - This guidance provides recommendations to sponsors about using minimal residual disease and complete response in multiple myeloma ...

Read more →

FDA issues guidance on modernising statistical methods for clinical trials

12 January 2026 - The US FDA today published draft guidance designed to facilitate the use of Bayesian methodologies in ...

Read more →

Agenda for the March 2026 PBAC meeting (9 January 2026)

9 January 2026 - The Department of Health has published an updated agenda for the March 2026 PBAC agenda (version ...

Read more →

PBS Expenditure and Prescriptions Report (2024-25)

22 December 2025 - The PBS Expenditure and Prescriptions Report 1 July 2024 to 30 June 2025 is now available. ...

Read more →

Public Summary Documents – September 2025 PBAC meeting

24 December 2025 - The Public Summary Documents (positive recommendations) from the September 2025 PBAC meeting are now available. ...

Read more →

The IQWiG methods: new version is effective immediately

19 December 2025 - With the General Methods 8.0, the new IQWiG methodology for determining minimum staffing levels for service ...

Read more →

Recommendations made by the PBAC - November 2025

19 December 2025 - Recommendations made by the PBAC in November 2025 relating to the listing of medicines on the ...

Read more →

Update from the PBAC (December 2025)

18 December 2025 - The final PBAC update for 2025 is now available. ...

Read more →

ICER publishes final evidence report on treatments for obesity

16 December 2025 - Independent committee voted unanimously on the positive net health benefit of all three treatments; final report ...

Read more →

ICER publishes evidence report on medication for smoking cessation

11 December 2025 - Cytisinicline is effective for smoking cessation; a 12 week course of cytisinicline would be cost effective ...

Read more →

ICER releases draft evidence report on therapies for IgA nephropathy

10 December 2025 - Public comment period now open until 14 January 2026; Requests to make oral comment during public ...

Read more →

EMA publishes agenda for 8-11 December 2025 CHMP meeting

8 December 2025 - The EMA has published a draft agenda for this week's CHMP meeting. ...

Read more →

Agenda for the December 2025 PBAC meeting

5 December 2025 - The agenda for the December 2025 PBAC meeting is now available. ...

Read more →

DUSC utilisation analysis public release documents (June 2025)

3 December 2025 - The utilisation analysis public release documents from the June 2025 DUSC meeting are now available. ...

Read more →